Diagnostic Accuracy of Quantitative PCR (Xpert MTB/RIF) for Tuberculous Meningitis in a High Burden Setting: A Prospective Study
Background:
Tuberculous meningitis (TBM) is difficult to diagnose promptly. The utility of the Xpert MTB/RIF test for the diagnosis of TBM remains unclear, and the effect of host- and sample-related factors on test performance is unknown. This study sought to evaluate the sensitivity and specificity of Xpert MTB/RIF for the diagnosis of TBM.
Methods and Findings:
235 South-African patients with a meningeal-like illness were categorised as having definite (culture or Amplicor PCR positive), probable (anti-TBM treatment initiated but microbiological confirmation lacking), or non-TBM. Xpert MTB/RIF accuracy was evaluated using 1 ml of uncentrifuged and, when available, 3 ml of centrifuged cerebrospinal fluid (CSF). To evaluate the incremental value of MTB/RIF over a clinically based diagnosis, test accuracy was compared to a clinical score (CS) derived using basic clinical and laboratory information.
Of 204 evaluable patients (of whom 87% were HIV-infected), 59 had definite TBM, 64 probable TBM, and 81 non-TBM. Overall sensitivity and specificity (95% CI) were 62% (48%–75%) and 95% (87%–99%), respectively. The sensitivity of Xpert MTB/RIF was significantly better than that of smear microscopy (62% versus 12%; p = 0.001) and significantly better than that of the CS (62% versus 30%; p = 0.001; C statistic 85% [79%–92%]). Xpert MTB/RIF sensitivity was higher when centrifuged versus uncentrifuged samples were used (82% [62%–94%] versus 47% [31%–61%]; p = 0.004). The combination of CS and Xpert MTB/RIF (Xpert MTB/RIF performed if CS<8) performed as well as Xpert MTB/RIF alone but with a ∼10% reduction in test usage. This overall pattern of results remained unchanged when the definite and probable TBM groups were combined. Xpert MTB/RIF was not useful in identifying TBM among HIV-uninfected individuals, although the sample was small. There was no evidence of PCR inhibition, and the limit of detection was ∼80 colony forming units per millilitre. Study limitations included a predominantly HIV-infected cohort and the limited number of culture-positive CSF samples.
Conclusions:
Xpert MTB/RIF may be a good rule-in test for the diagnosis of TBM in HIV-infected individuals from a tuberculosis-endemic setting, particularly when a centrifuged CSF pellet is used. Further studies are required to confirm these findings in different settings.
Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Diagnostic Accuracy of Quantitative PCR (Xpert MTB/RIF) for Tuberculous Meningitis in a High Burden Setting: A Prospective Study. PLoS Med 10(10): e32767. doi:10.1371/journal.pmed.1001536
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001536
Souhrn
Background:
Tuberculous meningitis (TBM) is difficult to diagnose promptly. The utility of the Xpert MTB/RIF test for the diagnosis of TBM remains unclear, and the effect of host- and sample-related factors on test performance is unknown. This study sought to evaluate the sensitivity and specificity of Xpert MTB/RIF for the diagnosis of TBM.
Methods and Findings:
235 South-African patients with a meningeal-like illness were categorised as having definite (culture or Amplicor PCR positive), probable (anti-TBM treatment initiated but microbiological confirmation lacking), or non-TBM. Xpert MTB/RIF accuracy was evaluated using 1 ml of uncentrifuged and, when available, 3 ml of centrifuged cerebrospinal fluid (CSF). To evaluate the incremental value of MTB/RIF over a clinically based diagnosis, test accuracy was compared to a clinical score (CS) derived using basic clinical and laboratory information.
Of 204 evaluable patients (of whom 87% were HIV-infected), 59 had definite TBM, 64 probable TBM, and 81 non-TBM. Overall sensitivity and specificity (95% CI) were 62% (48%–75%) and 95% (87%–99%), respectively. The sensitivity of Xpert MTB/RIF was significantly better than that of smear microscopy (62% versus 12%; p = 0.001) and significantly better than that of the CS (62% versus 30%; p = 0.001; C statistic 85% [79%–92%]). Xpert MTB/RIF sensitivity was higher when centrifuged versus uncentrifuged samples were used (82% [62%–94%] versus 47% [31%–61%]; p = 0.004). The combination of CS and Xpert MTB/RIF (Xpert MTB/RIF performed if CS<8) performed as well as Xpert MTB/RIF alone but with a ∼10% reduction in test usage. This overall pattern of results remained unchanged when the definite and probable TBM groups were combined. Xpert MTB/RIF was not useful in identifying TBM among HIV-uninfected individuals, although the sample was small. There was no evidence of PCR inhibition, and the limit of detection was ∼80 colony forming units per millilitre. Study limitations included a predominantly HIV-infected cohort and the limited number of culture-positive CSF samples.
Conclusions:
Xpert MTB/RIF may be a good rule-in test for the diagnosis of TBM in HIV-infected individuals from a tuberculosis-endemic setting, particularly when a centrifuged CSF pellet is used. Further studies are required to confirm these findings in different settings.
Please see later in the article for the Editors' Summary
Zdroje
1. World Health Organization (2011) Global tuberculosis control. Geneva: World Health Organization.
2. KwanCK, ErnstJD (2011) HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev 24: 351–376.
3. Braunwald E, Fauchi AS, Kasper DL, Hauser SL, Longo DL, et al.. (2001) Harrisons's principles of internal medicine. New York: McGraw-Hill. 1028 p.
4. OzbayB, UzunK (2002) Extrapulmonary tuberculosis in high prevalence of tuberculosis and low prevalence of HIV. Clin Chest Med 23: 351–354.
5. Garcia-MoncoJC (1999) Central nervous system tuberculosis. Neurol Clin 17: 737–759.
6. KarsteadtAS, ValtatchanovaS, BarriereR, Crewe-BrownHH (1998) Tuberculous meningitis in South African urban adults. QJM 91: 743–747.
7. RockRB, OlinM, BakerCA, MolitorTW, PetersonPK (2008) Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev 21: 243–261.
8. VinnardC, MacgregorRR (2009) Tuberculous meningitis in HIV-infected individuals. Curr HIV/AIDS Rep 6: 139–145.
9. PaiM, FloresLL, PaiN, HubbardA, RileyLW, et al. (2003) Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 3: 633–643.
10. ThereseKL, JayanthiU, MadhavanHN (2005) Application of nested polymerase chain reaction (nPCR) using MPB 64 gene primers to detect Mycobacterium tuberculosis DNA in clinical specimens from extrapulmonary tuberculosis patients. Indian J Med Res 122: 165–170.
11. BoehmeCC, NabetaP, HillemannD, NicolMP, ShenaiS, et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363: 1005–1015.
12. BowlesEC, FreyeeB, van IngenJ, MulderB, BoereeMJ, et al. (2011) Xpert MTB/RIF®, a novel automated polymerase chain reaction-based tool for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 15: 988–989.
13. TheronG, PeterJ, van Zyl-SmitR, MishraH, StreicherE, et al. (2011) Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 184: 132–140.
14. LawnSD, NicolMP (2011) Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol 6: 1067–1082.
15. SimmonsCP, ThwaitesGE, QuyenNT, TorokE, HoangDM, et al. (2006) Pretreatment intracerebral and peripheral blood immune responses in Vietnamese adults with tuberculous meningitis: diagnostic value and relationship to disease severity and outcome. J Immunol 176: 2007–2014.
16. ThwaitesG, ChauTT, MaiNT, DrobniewskiF, McAdamK, et al. (2000) Tuberculous meningitis. J Neurol Neurosurg Psychiatry 68: 289–299.
17. ThwaitesG, FisherM, HemingwayC, ScottG, SolomonT, et al. (2009) British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 59: 167–187.
18. SchaafHS, MollAP, DhedaK (2009) Multidrug- and extensively drug-resistant tuberculosis in Africa and South America: epidemiology, diagnosis and management in adults and children. Clin Chest Med 30: 667–683.
19. PaiM, LingDI (2008) Rapid diagnosis of extrapulmonary tuberculosis using nucleic acid amplification tests: what is the evidence? Future Microbiol 3: 1–4.
20. RajaS, ChingJ, XiL, HughesSJ, ChangR, et al. (2005) Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin Chem 51: 882–890.
21. Cepheid (2009 April) Xpert MTB/RIF, 300-7810 Rev. A [package insert]. Sunnyvale (California): Cepheid.
22. HelbD, JonesM, StoryE, BoehmeC, WallaceE, et al. (2010) Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 48: 229–237.
23. PatelVB, SinghR, ConnollyC, CoovadiaY, PeerAK, et al. (2010) Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population. Am J Respir Crit Care Med 182: 569–577.
24. BhigjeeAI, PadayacheeR, ParukH, Hallwirth-PillayKD, MaraisS, et al. (2007) Diagnosis of tuberculous meningitis: clinical and laboratory parameters. Int J Infect Dis 11: 348–354.
25. JarvisJN, MeintjesG, WilliamsA, BrownY, CredeT, et al. (2010) Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect Dis 10: 67.
26. BlakemoreR, NabetaP, DavidowAL, VadwaiV, TahirliR, et al. (2011) A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay. Am J Respir Crit Care Med 184: 1076–1084.
27. FriedrichSO, von Groote-BidlingmaierF, DiaconAH (2011) Xpert MTB/RIF assay for the diagnosis of pleural tuberculosis. J Clin Microbiol 49: 4341–4342.
28. ChangK, LuW, WangJ, ZhangK, JiaS, et al. (2012) Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect 64: 580–588.
29. HillemannD, Rusch-GerdesS, BoehmeC, RichterE (2011) Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. J Clin Microbiol 49: 1202–1205.
30. IoannidisP, PapaventsisD, KarabelaS, NikolaouS, PanagiM, et al. (2011) Cepheid GeneXpert MTB/RIF Assay for Mycobacterium tuberculosis detection and rifampin resistance identification in patients with high clinical suspicion of TB and smear negative microscopy. J Clin Microbiol 49: 3068–3070.
31. VadwaiV, BoehmeC, NabetaP, ShettyA, AllandD, et al. (2011) Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? J Clin Microbiol 49: 2540–2545.
32. CausseM, RuizP, Gutierrez-ArocaJB, CasalM (2011) Comparison of two molecular methods for rapid diagnosis of extrapulmonary tuberculosis. J Clin Microbiol 49: 3065–3067.
33. EingBR, BeckerA, SohnsA, RingelmannR (1998) Comparison of Roche Cobas Amplicor Mycobacterium tuberculosis assay with in-house PCR and culture for detection of M. tuberculosis. J Clin Microbiol 36: 2023–2029.
34. JonssonB, RidellM (2003) The Cobas Amplicor MTB test for detection of Mycobacterium tuberculosis complex from respiratory and non-respiratory clinical specimens. Scand J Infect Dis 35: 372–377.
35. ThwaitesGE, ChauTT, StepniewskaK, PhuNH, ChuongLV, et al. (2002) Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 360: 1287–1292.
36. ThwaitesGE, ChauTT, FarrarJJ (2004) Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol 42: 378–379.
37. GargRK (1999) Tuberculosis of the central nervous system. Postgrad Med J 75: 133–140.
38. van Zyl-SmitRN, BinderA, MeldauR, MishraH, SemplePL, et al. (2011) Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden. PLoS ONE 6: e28815 doi:10.1371/journal.pone.0028815
39. TheronG, PeterJ, DhedaK (2012) Characteristics of Xpert MTB/RIF-negative patients with pulmonary tuberculosis. Clin Infect Dis 55: 472–473.
40. RatnamohanVM, CunninghamAL, RawlinsonWD (1998) Removal of inhibitors of CSF-PCR to improve diagnosis of herpesviral encephalitis. J Virol Methods 72: 59–65.
41. Welinder-OlssonC, DotevallL, HogevikH, JungneliusR, TrollforsB, et al. (2007) Comparison of broad-range bacterial PCR and culture of cerebrospinal fluid for diagnosis of community-acquired bacterial meningitis. Clin Microbiol Infect 13: 879–886.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2013 Číslo 10
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- Utility of the Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis
- Modelling the Strategic Use of Antiretroviral Therapy for the Treatment and Prevention of HIV
- Diagnostic Accuracy of Quantitative PCR (Xpert MTB/RIF) for Tuberculous Meningitis in a High Burden Setting: A Prospective Study
- Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study